The cytotoxic T lymphocyte assay for evaluating cell-mediated immune function

Area of Science:

• Immunology
• Toxicology
• Virology

Background:

• Cell-mediated immunity (CMI) evaluation is vital for assessing immunotoxic risk.
• Cytotoxic T Lymphocyte (CTL) responses are key functional measures of acquired immune defense against viral infections and cancer.
• CTL responses involve antigen-presenting cells, CD4(+) T helper cells, and CD8(+) T effector cells, and assess MHC class I and II antigen presentation.

Purpose of the Study:

• To highlight the significance of CTL assays in evaluating immunotoxicity.
• To present a mouse CTL assay model for assessing immune responses.
• To demonstrate the utility of CTL assays in predicting health risks associated with immunotoxic agents.

Main Methods:

• Utilizing a mouse model to assess cytotoxic T lymphocyte (CTL) responses.
• Employing an influenza virus model to stimulate and measure CTL activity.
• Evaluating antigen presentation through both MHC class I and class II molecules.

Main Results:

• The study demonstrates the feasibility of using a mouse CTL assay for immunotoxicity assessment.
• The CTL assay effectively measures cell-mediated immune responses relevant to viral infections and cancer.
• The assay's dependence on MHC class I and II presentation makes it a comprehensive tool.

Conclusions:

• Cytotoxic T lymphocyte (CTL) assays are valuable functional measures for assessing cell-mediated immunity and predicting immunotoxic risks.
• The presented mouse CTL assay against influenza virus serves as a robust model for immunotoxicity evaluation.
• Effective antigen presentation via MHC class I and II molecules, assessed by CTL assays, is critical for immune defense and risk assessment.